SavedAdd your journal

Journals / İstanbul Üniversitesi Florence Nightingale Hemşirelik Yüksekokulu Dergisi / 2012 / Cilt: 20 - Sayı: 3

What should being to prevent of pain, echymosis and heamotoma in subcutaneous heparin injections?

Subkütan heparin enjeksiyonlarında ekimoz, hematom ve ağrıyı önlemek için nelere dikkat edilmeli?

Mağfiret KAŞIKÇI
Gülçin AVŞAR
Pages
239–246
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, the factors which is effective on the development of the complications occured after administering heparin injection, and the studies concerning to the subject were examined.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Today, subcutaneous heparin injections are commonly used for a variety of treatments.
📊
Key Findings & Data:After the subcutaneous heparin injections, ecchymosis, haematoma occurence and pain are the most common complications.
💡
Conclusion & Impact:In this article, the factors which is effective on the development of the complications occured after administering heparin injection, and the studies concerning to the subject were examined.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Today, subcutaneous heparin injections are commonly used for a variety of treatments. After the subcutaneous heparin injections, ecchymosis, haematoma occurence and pain are the most common complications. In this article, the factors which is effective on the development of the complications occured after administering heparin injection, and the studies concerning to the subject were examined.

Özet

Günümüzde subkütan heparin enjeksiyonu çeşitli tedavilerde yaygın bir şekilde kullanılmaktadır. Subkütan heparin enjeksiyonundan sonra ekimoz, hematom ve ağrı gelişimi en yaygın komplikasyonlardandır. Bu makalede heparin enjeksiyonundan sonra ortaya çıkan komplikasyonların oluşumunda etkili olan etmenler ve bu konuda yapılmış çalışmalar gözden geçirilmiştir.

🔖

Cite This Article

KAŞIKÇI, M., AVŞAR, G. (2022). What should being to prevent of pain, echymosis and heamotoma in subcutaneous heparin injections?. İstanbul Üniversitesi Florence Nightingale Hemşirelik Yüksekokulu Dergisi, Cilt: 20 - Sayı: 3, 239–246. https://ajindex.com/articles/550960

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Akça Ay, F. (2008) (Ed.). İlaç Uygulamaları. Temel Hemşirelik Kavramlar, İlkeler, Uygulamalar. Medikal Yayıncılık, İstanbul, 337-341.
  2. Akpınar Balcı R., Çelebioğlu, A. (2008). Effect of injection duration on bruising associated with subcutaneous heparin: A quasi- experimental within-subject design. International Journal of Nursing Studies, 45: 812–817.
  3. Avşar, G., Kaşıkçı, M. (2010). Subkütan heparin uygulamalarında dört farklı yöntemin ekimoz, hematom ve ağrıya neden olma yönünden değerlendirilmesi. Yayınlanmamış Doktora Tezi, Atatürk Üniversitesi Sağlık Bilimleri Fakültesi, Erzurum, 36-37
  4. Chan, H. (2001). Effect of injection duration on site-pain intensity and bruising associated with subcutaneous heparin. Journal of Advenced Nursing, 35(6): 882-892. Clexan Prekpektüsü, www.clexan.com.tr (10.08.2009).
  5. Conaghan, P. (1993). Subcutaneous heparin injections bruising. Surgical Nurse, 25-27.
  6. Craven, R. F., Hirnle, C. J. (2003) Fundamentals of Nursing: Human Health and Function. J.B. Lippincott Company, Philadelphia, 513-575.
  7. Dökmeci, İ. (2000). Farmakolojide Temel Kavramlar. Tayf Ofset, İstanbul, 753-763.
  8. Elkin, M. K., Perry, A. G., Potter, P. A. (Eds.) (2004). Nursing Interventions and Clinical Skills 3. baskı, Mosby, St. Louis: Missouri, 466-471. Fraxiparine Prekpektüsü, www.faxiparine. com.tr (10.08.2009).
  9. Ginsberg, J. A., Crowther, M. A., White, R. H., Ortel, T. L. (2001). An- ticoagulation therapy. The American Society of Hematology, 1:27-29
  10. Gümüş, N.Y. (2000). İlaç etkinliğinde hemşirenin vazgeçilmezliği. I. Uluslar Arası VII. Ulusal Hemşirelik Kongresi Kitabı, İstanbul, 44. Hadley, S. A., Chang, M., Rogers, K. (1996). Effect of syringe size on bruising following subcutaneous heparin injection. American Journal of Critical Care, 5(4): 271-276.
  11. Hall, A. M. (2004).
  12. Administration of injections. Elkin, M. K., Perry, A. G., Potter, P. A. (Eds.). Nursing Interventions and Clinical Skills. Mosby, St. Louis Missouri, 471–474.
  13. Harkreader, H., Hogan, M. A. (2004). Caring and Clinical Judg- ment. Fundamentals of Nursing. Elsevier Science, USA, 387-450.
  14. Hirsh, J., Anand, S. S., Halperin, J. L., Fuster, V. (2001) Guide to anticoagulant therapy: Heparin. Circulation, 103(24), 2994. Jafari, S., Bolourchifard, F. (2006). Comparing the effect of two types injection duration on site pain and bruising associated with subcutaneous heparin. European Journal of Pain, 10; 40-51.
  15. Karabacak, G. (2010). Parenteral ilaç uygulamaları. Sabuncu, N., Akça Ay, F. (Eds.). Klinik Beceril